HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A study of topical methyl-aminolaevulinate red-light photodynamic therapy in the treatment of actinic keratosis in Chinese patients: a Singaporean experience.

AbstractBACKGROUND:
The incidence of skin cancers has been increasing in Singapore, owing to the country's location near the equator and its ageing population. Topical photodynamic therapy (PDT) is a treatment method employing light and a topical photosensitizer to treat actinic keratosis (AK). Most published data to date on PDT have been drawn from studies of patient with Fitzpatrick skin phototypes I and II.
AIM:
To evaluate the effectiveness of PDT in the treatment of AK in patients with skin phototype IV in Singapore.
METHODS:
This was a retrospective analysis of 13 East Asian patients with AK treated with PDT at the National Skin Centre, Singapore, from 2006 to 2013.
RESULTS:
The overall clearance rate of AK at 3 months was 81.8% (9 of 11 patients; the other 2 were lost to follow-up). Mild to moderate pain during therapy was a common adverse event.
CONCLUSIONS:
PDT is a useful treatment method for AK in East Asian patients with skin phototype IV. Further larger prospective studies will be needed to evaluate its overall efficacy in East Asian patients.
AuthorsC C Oh, T S C Theng, W S Chong
JournalClinical and experimental dermatology (Clin Exp Dermatol) Vol. 40 Issue 5 Pg. 502-6 (Jul 2015) ISSN: 1365-2230 [Electronic] England
PMID25800146 (Publication Type: Evaluation Study, Journal Article)
Copyright© 2015 British Association of Dermatologists.
Chemical References
  • Photosensitizing Agents
  • Aminolevulinic Acid
Topics
  • Aged
  • Aged, 80 and over
  • Aminolevulinic Acid (therapeutic use)
  • Asian People
  • Female
  • Humans
  • Keratosis, Actinic (drug therapy, ethnology)
  • Male
  • Pain (etiology)
  • Photochemotherapy (adverse effects, methods)
  • Photosensitizing Agents (therapeutic use)
  • Retrospective Studies
  • Singapore

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: